Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2)

 FGF10_HUMAN             Reviewed;         208 AA.
O15520; C7FDY0; Q6FHR3; Q6FHT6; Q96P59;
15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
01-JAN-1998, sequence version 1.
25-OCT-2017, entry version 158.
RecName: Full=Fibroblast growth factor 10;
Short=FGF-10;
AltName: Full=Keratinocyte growth factor 2;
Flags: Precursor;
Name=FGF10;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Lung;
PubMed=9287324; DOI=10.1074/jbc.272.37.23191;
Emoto H., Tagashira S., Mattei M.-G., Yamasaki M., Hashimoto G.,
Katsumata T., Negoro T., Nakatsuka M., Birnbaum D., Coulier F.,
Itoh N.;
"Structure and expression of human fibroblast growth factor-10.";
J. Biol. Chem. 272:23191-23194(1997).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Lung;
Jimenez P.A., Gruber J.R., Liu B., Feng P., Florence C., Blunt A.,
Huddleston K.A., Teliska M., Alfonso P., Coleman T.A., Ornitz D.M.,
Dillon P.A., Duan R.D.;
"Cutaneous wound healing by keratinocyte growth factor 2.";
Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [MRNA].
Zhang Y., Zhang B., Zhou Y., Peng X., Yuan J., Qiang B.;
Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [MRNA].
Nakhla A.M., Hryb D.J., Kahn S.M., Romas N.A., Rosner W.;
"Expression of FGF10 in human prostate stromal cells.";
Submitted (JUL-2009) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
Korn B., Zuo D., Hu Y., LaBaer J.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
NIEHS SNPs program;
Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[9]
INTERACTION WITH FGFBP1.
PubMed=15806171; DOI=10.1038/sj.onc.1208560;
Beer H.-D., Bittner M., Niklaus G., Munding C., Max N., Goppelt A.,
Werner S.;
"The fibroblast growth factor binding protein is a novel interaction
partner of FGF-7, FGF-10 and FGF-22 and regulates FGF activity:
implications for epithelial repair.";
Oncogene 24:5269-5277(2005).
[10]
INTERACTION WITH FGFR1 AND FGFR2, AND FUNCTION IN STIMULATION OF CELL
PROLIFERATION.
PubMed=16597617; DOI=10.1074/jbc.M601252200;
Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M.,
Ornitz D.M.;
"Receptor specificity of the fibroblast growth factor family. The
complete mammalian FGF family.";
J. Biol. Chem. 281:15694-15700(2006).
[11]
REVIEW.
PubMed=20094046; DOI=10.1038/nrc2780;
Turner N., Grose R.;
"Fibroblast growth factor signalling: from development to cancer.";
Nat. Rev. Cancer 10:116-129(2010).
[12]
X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 69-208 IN COMPLEX WITH FGFR2.
PubMed=12591959; DOI=10.1073/pnas.0436500100;
Yeh B.K., Igarashi M., Eliseenkova A.V., Plotnikov A.N., Sher I.,
Ron D., Aaronson S.A., Mohammadi M.;
"Structural basis by which alternative splicing confers specificity in
fibroblast growth factor receptors.";
Proc. Natl. Acad. Sci. U.S.A. 100:2266-2271(2003).
[13]
INVOLVEMENT IN ALSG.
PubMed=15654336; DOI=10.1038/ng1507;
Entesarian M., Matsson H., Klar J., Bergendal B., Olson L.,
Arakaki R., Hayashi Y., Ohuchi H., Falahat B., Bolstad A.I.,
Jonsson R., Wahren-Herlenius M., Dahl N.;
"Mutations in the gene encoding fibroblast growth factor 10 are
associated with aplasia of lacrimal and salivary glands.";
Nat. Genet. 37:125-127(2005).
[14]
VARIANT LADDS ARG-156.
PubMed=16630169; DOI=10.1111/j.1399-0004.2006.00597.x;
Milunsky J.M., Zhao G., Maher T.A., Colby R., Everman D.B.;
"LADD syndrome is caused by FGF10 mutations.";
Clin. Genet. 69:349-354(2006).
[15]
VARIANT LADDS PHE-106.
PubMed=16501574; DOI=10.1038/ng1757;
Rohmann E., Brunner H.G., Kayserili H., Uyguner O., Nuernberg G.,
Lew E.D., Dobbie A., Eswarakumar V.P., Uzumcu A., Ulubil-Emeroglu M.,
Leroy J.G., Li Y., Becker C., Lehnerdt K., Cremers C.W.R.J.,
Yueksel-Apak M., Nuernberg P., Kubisch C., Schlessinger J.,
van Bokhoven H., Wollnik B.;
"Mutations in different components of FGF signaling in LADD
syndrome.";
Nat. Genet. 38:414-417(2006).
-!- FUNCTION: Plays an important role in the regulation of embryonic
development, cell proliferation and cell differentiation. Required
for normal branching morphogenesis. May play a role in wound
healing. {ECO:0000269|PubMed:16597617}.
-!- SUBUNIT: Interacts with FGFR1 and FGFR2. Interacts with FGFBP1.
{ECO:0000269|PubMed:12591959, ECO:0000269|PubMed:15806171,
ECO:0000269|PubMed:16597617}.
-!- INTERACTION:
P21802:FGFR2; NbExp=2; IntAct=EBI-1035684, EBI-1028658;
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
-!- DISEASE: Aplasia of lacrimal and salivary glands (ALSG)
[MIM:180920]: A rare condition characterized by dry conjunctival
mucosae, irritable eyes, epiphora (constant tearing), and
xerostomia (dryness of the mouth), which increases risk of dental
erosion, dental caries, periodontal disease, and oral infections.
ALSG has variable expressivity, and affected individuals may have
aplasia or hypoplasia of the lacrimal, parotid, submandibular, and
sublingual glands and absence of the lacrimal puncta.
{ECO:0000269|PubMed:15654336}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- DISEASE: Lacrimo-auriculo-dento-digital syndrome (LADDS)
[MIM:149730]: An autosomal dominant ectodermal dysplasia, a
heterogeneous group of disorders due to abnormal development of
two or more ectodermal structures. Lacrimo-auriculo-dento-digital
syndrome is characterized by aplastic/hypoplastic lacrimal and
salivary glands and ducts, cup-shaped ears, hearing loss,
hypodontia and enamel hypoplasia, and distal limb segments
anomalies. In addition to these cardinal features, facial
dysmorphism, malformations of the kidney and respiratory system
and abnormal genitalia have been reported. Craniosynostosis and
severe syndactyly are not observed. {ECO:0000269|PubMed:16501574,
ECO:0000269|PubMed:16630169}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the heparin-binding growth factors family.
{ECO:0000305}.
-!- WEB RESOURCE: Name=NIEHS-SNPs;
URL="http://egp.gs.washington.edu/data/fgf10/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AB002097; BAA22331.1; -; mRNA.
EMBL; U67918; AAB61991.1; -; mRNA.
EMBL; AF411527; AAL05875.1; -; mRNA.
EMBL; GQ351295; ACU00617.1; -; mRNA.
EMBL; CR541665; CAG46466.1; -; mRNA.
EMBL; CR541688; CAG46489.1; -; mRNA.
EMBL; AY604046; AAS99733.1; -; Genomic_DNA.
EMBL; CH471119; EAW56075.1; -; Genomic_DNA.
EMBL; BC069561; AAH69561.1; -; mRNA.
EMBL; BC105021; AAI05022.1; -; mRNA.
EMBL; BC105023; AAI05024.1; -; mRNA.
CCDS; CCDS3950.1; -.
RefSeq; NP_004456.1; NM_004465.1.
RefSeq; XP_005248321.1; XM_005248264.3.
UniGene; Hs.248049; -.
UniGene; Hs.664499; -.
PDB; 1NUN; X-ray; 2.90 A; A=64-208.
PDBsum; 1NUN; -.
ProteinModelPortal; O15520; -.
SMR; O15520; -.
BioGrid; 108546; 7.
DIP; DIP-6037N; -.
IntAct; O15520; 4.
MINT; MINT-257957; -.
STRING; 9606.ENSP00000264664; -.
iPTMnet; O15520; -.
PhosphoSitePlus; O15520; -.
BioMuta; FGF10; -.
PaxDb; O15520; -.
PeptideAtlas; O15520; -.
PRIDE; O15520; -.
DNASU; 2255; -.
Ensembl; ENST00000264664; ENSP00000264664; ENSG00000070193.
GeneID; 2255; -.
KEGG; hsa:2255; -.
UCSC; uc003jog.2; human.
CTD; 2255; -.
DisGeNET; 2255; -.
EuPathDB; HostDB:ENSG00000070193.4; -.
GeneCards; FGF10; -.
HGNC; HGNC:3666; FGF10.
HPA; CAB010315; -.
MalaCards; FGF10; -.
MIM; 149730; phenotype.
MIM; 180920; phenotype.
MIM; 602115; gene.
neXtProt; NX_O15520; -.
OpenTargets; ENSG00000070193; -.
Orphanet; 86815; Aplasia of lacrimal and salivary glands.
Orphanet; 2363; Lacrimoauriculodentodigital syndrome.
PharmGKB; PA28106; -.
eggNOG; KOG3885; Eukaryota.
eggNOG; ENOG4111IPH; LUCA.
GeneTree; ENSGT00760000118859; -.
HOGENOM; HOG000236341; -.
HOVERGEN; HBG007580; -.
InParanoid; O15520; -.
KO; K04358; -.
OMA; SSIPVTC; -.
OrthoDB; EOG091G0NAY; -.
PhylomeDB; O15520; -.
TreeFam; TF317805; -.
Reactome; R-HSA-109704; PI3K Cascade.
Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
Reactome; R-HSA-190370; FGFR1b ligand binding and activation.
Reactome; R-HSA-190377; FGFR2b ligand binding and activation.
Reactome; R-HSA-2033519; Activated point mutants of FGFR2.
Reactome; R-HSA-210747; Regulation of gene expression in early pancreatic precursor cells.
Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
Reactome; R-HSA-5654219; Phospholipase C-mediated cascade: FGFR1.
Reactome; R-HSA-5654221; Phospholipase C-mediated cascade, FGFR2.
Reactome; R-HSA-5654687; Downstream signaling of activated FGFR1.
Reactome; R-HSA-5654688; SHC-mediated cascade:FGFR1.
Reactome; R-HSA-5654689; PI-3K cascade:FGFR1.
Reactome; R-HSA-5654693; FRS-mediated FGFR1 signaling.
Reactome; R-HSA-5654695; PI-3K cascade:FGFR2.
Reactome; R-HSA-5654699; SHC-mediated cascade:FGFR2.
Reactome; R-HSA-5654700; FRS-mediated FGFR2 signaling.
Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
Reactome; R-HSA-5655253; Signaling by FGFR2 in disease.
Reactome; R-HSA-5658623; FGFRL1 modulation of FGFR1 signaling.
Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
SignaLink; O15520; -.
SIGNOR; O15520; -.
EvolutionaryTrace; O15520; -.
GeneWiki; FGF10; -.
GenomeRNAi; 2255; -.
PRO; PR:O15520; -.
Proteomes; UP000005640; Chromosome 5.
Bgee; ENSG00000070193; -.
CleanEx; HS_FGF10; -.
ExpressionAtlas; O15520; baseline and differential.
Genevisible; O15520; HS.
GO; GO:0009986; C:cell surface; IDA:UniProtKB.
GO; GO:0005576; C:extracellular region; TAS:Reactome.
GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; TAS:Reactome.
GO; GO:0042056; F:chemoattractant activity; IDA:UniProtKB.
GO; GO:0005104; F:fibroblast growth factor receptor binding; IDA:UniProtKB.
GO; GO:0008083; F:growth factor activity; IDA:UniProtKB.
GO; GO:0008201; F:heparin binding; IDA:UniProtKB.
GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
GO; GO:0005111; F:type 2 fibroblast growth factor receptor binding; IPI:UniProtKB.
GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
GO; GO:0000187; P:activation of MAPK activity; IDA:UniProtKB.
GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
GO; GO:0060667; P:branch elongation involved in salivary gland morphogenesis; IEA:Ensembl.
GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB.
GO; GO:0060436; P:bronchiole morphogenesis; IEA:Ensembl.
GO; GO:0060449; P:bud elongation involved in lung branching; IEA:Ensembl.
GO; GO:0060447; P:bud outgrowth involved in lung branching; IDA:MGI.
GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl.
GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
GO; GO:0030538; P:embryonic genitalia morphogenesis; IEA:Ensembl.
GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
GO; GO:0010631; P:epithelial cell migration; IEA:Ensembl.
GO; GO:0050673; P:epithelial cell proliferation; IDA:UniProtKB.
GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl.
GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB.
GO; GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl.
GO; GO:0048807; P:female genitalia morphogenesis; IEA:Ensembl.
GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
GO; GO:0060595; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; IDA:MGI.
GO; GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl.
GO; GO:0070384; P:Harderian gland development; IEA:Ensembl.
GO; GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl.
GO; GO:0038111; P:interleukin-7-mediated signaling pathway; TAS:Reactome.
GO; GO:0043616; P:keratinocyte proliferation; IEA:Ensembl.
GO; GO:0032808; P:lacrimal gland development; IMP:UniProtKB.
GO; GO:0060174; P:limb bud formation; IEA:Ensembl.
GO; GO:0060428; P:lung epithelium development; IDA:MGI.
GO; GO:0061115; P:lung proximal/distal axis specification; IEA:Ensembl.
GO; GO:0060430; P:lung saccule development; IMP:UniProtKB.
GO; GO:0048808; P:male genitalia morphogenesis; IEA:Ensembl.
GO; GO:0060615; P:mammary gland bud formation; IEA:Ensembl.
GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
GO; GO:0060915; P:mesenchymal cell differentiation involved in lung development; IEA:Ensembl.
GO; GO:0060496; P:mesenchymal-epithelial cell signaling involved in lung development; IEA:Ensembl.
GO; GO:0001823; P:mesonephros development; IEP:UniProtKB.
GO; GO:0001656; P:metanephros development; IEP:UniProtKB.
GO; GO:0003338; P:metanephros morphogenesis; IEA:Ensembl.
GO; GO:0042693; P:muscle cell fate commitment; IEA:Ensembl.
GO; GO:0071157; P:negative regulation of cell cycle arrest; IDA:UniProtKB.
GO; GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl.
GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
GO; GO:0001759; P:organ induction; IEA:Ensembl.
GO; GO:0030916; P:otic vesicle formation; IEA:Ensembl.
GO; GO:0031016; P:pancreas development; IEA:Ensembl.
GO; GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome.
GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
GO; GO:0050918; P:positive chemotaxis; IDA:UniProtKB.
GO; GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB.
GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl.
GO; GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:UniProtKB.
GO; GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB.
GO; GO:0045740; P:positive regulation of DNA replication; IMP:UniProtKB.
GO; GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProtKB.
GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB.
GO; GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; NAS:UniProtKB.
GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
GO; GO:0071338; P:positive regulation of hair follicle cell proliferation; IDA:UniProtKB.
GO; GO:0051549; P:positive regulation of keratinocyte migration; IDA:UniProtKB.
GO; GO:0010838; P:positive regulation of keratinocyte proliferation; IDA:UniProtKB.
GO; GO:0050671; P:positive regulation of lymphocyte proliferation; IDA:UniProtKB.
GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB.
GO; GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl.
GO; GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl.
GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
GO; GO:0050677; P:positive regulation of urothelial cell proliferation; IDA:UniProtKB.
GO; GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl.
GO; GO:0070352; P:positive regulation of white fat cell proliferation; IEA:Ensembl.
GO; GO:0060513; P:prostatic bud formation; IEA:Ensembl.
GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
GO; GO:0060019; P:radial glial cell differentiation; ISS:UniProtKB.
GO; GO:0032925; P:regulation of activin receptor signaling pathway; IEA:Ensembl.
GO; GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IEA:Ensembl.
GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
GO; GO:0046877; P:regulation of saliva secretion; IMP:UniProtKB.
GO; GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl.
GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
GO; GO:0007431; P:salivary gland development; IMP:UniProtKB.
GO; GO:0061033; P:secretion by lung epithelial cell involved in lung growth; IDA:UniProtKB.
GO; GO:0060879; P:semicircular canal fusion; IEA:Ensembl.
GO; GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl.
GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
GO; GO:0048536; P:spleen development; IEA:Ensembl.
GO; GO:0060661; P:submandibular salivary gland formation; IEA:Ensembl.
GO; GO:0070075; P:tear secretion; IMP:UniProtKB.
GO; GO:0048538; P:thymus development; IDA:UniProtKB.
GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
GO; GO:0042246; P:tissue regeneration; IEA:Ensembl.
GO; GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl.
GO; GO:0050674; P:urothelial cell proliferation; IDA:UniProtKB.
GO; GO:0050872; P:white fat cell differentiation; IEA:Ensembl.
GO; GO:0042060; P:wound healing; IDA:UniProtKB.
CDD; cd00058; FGF; 1.
InterPro; IPR028252; FGF10.
InterPro; IPR002209; Fibroblast_GF_fam.
InterPro; IPR008996; IL1/FGF.
PANTHER; PTHR11486; PTHR11486; 1.
PANTHER; PTHR11486:SF21; PTHR11486:SF21; 1.
Pfam; PF00167; FGF; 1.
PRINTS; PR00263; HBGFFGF.
SMART; SM00442; FGF; 1.
SUPFAM; SSF50353; SSF50353; 1.
PROSITE; PS00247; HBGF_FGF; 1.
1: Evidence at protein level;
3D-structure; Complete proteome; Disease mutation;
Ectodermal dysplasia; Glycoprotein; Growth factor;
Lacrimo-auriculo-dento-digital syndrome; Reference proteome; Secreted;
Signal.
SIGNAL 1 37 {ECO:0000255}.
CHAIN 38 208 Fibroblast growth factor 10.
/FTId=PRO_0000008981.
COMPBIAS 52 62 Poly-Ser.
CARBOHYD 51 51 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 196 196 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
VARIANT 106 106 C -> F (in LADDS; dbSNP:rs104893885).
{ECO:0000269|PubMed:16501574}.
/FTId=VAR_029888.
VARIANT 156 156 I -> R (in LADDS; dbSNP:rs104893886).
{ECO:0000269|PubMed:16630169}.
/FTId=VAR_029889.
CONFLICT 43 43 D -> V (in Ref. 5; CAG46489).
{ECO:0000305}.
CONFLICT 120 120 V -> A (in Ref. 3; AAL05875).
{ECO:0000305}.
CONFLICT 134 134 M -> R (in Ref. 3; AAL05875).
{ECO:0000305}.
HELIX 70 73 {ECO:0000244|PDB:1NUN}.
STRAND 76 84 {ECO:0000244|PDB:1NUN}.
STRAND 89 92 {ECO:0000244|PDB:1NUN}.
STRAND 98 101 {ECO:0000244|PDB:1NUN}.
STRAND 111 117 {ECO:0000244|PDB:1NUN}.
STRAND 120 125 {ECO:0000244|PDB:1NUN}.
TURN 126 129 {ECO:0000244|PDB:1NUN}.
STRAND 130 134 {ECO:0000244|PDB:1NUN}.
STRAND 138 145 {ECO:0000244|PDB:1NUN}.
STRAND 150 156 {ECO:0000244|PDB:1NUN}.
STRAND 162 171 {ECO:0000244|PDB:1NUN}.
STRAND 174 177 {ECO:0000244|PDB:1NUN}.
HELIX 189 191 {ECO:0000244|PDB:1NUN}.
HELIX 197 199 {ECO:0000244|PDB:1NUN}.
STRAND 201 205 {ECO:0000244|PDB:1NUN}.
SEQUENCE 208 AA; 23436 MW; C0A0705C108680B3 CRC64;
MWKWILTHCA SAFPHLPGCC CCCFLLLFLV SSVPVTCQAL GQDMVSPEAT NSSSSSFSSP
SSAGRHVRSY NHLQGDVRWR KLFSFTKYFL KIEKNGKVSG TKKENCPYSI LEITSVEIGV
VAVKAINSNY YLAMNKKGKL YGSKEFNNDC KLKERIEENG YNTYASFNWQ HNGRQMYVAL
NGKGAPRRGQ KTRRKNTSAH FLPMVVHS


Related products :

Catalog number Product name Quantity
E0636h ELISA kit FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Homo sapiens,Human,Keratinocyte growth factor,KGF,KGF 96T
E0636h ELISA FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Homo sapiens,Human,Keratinocyte growth factor,KGF,KGF 96T
U0636h CLIA FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Homo sapiens,Human,Keratinocyte growth factor,KGF,KGF 96T
E0636r ELISA kit Fgf7,FGF-7,Fgf-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Kgf,Rat,Rattus norvegicus 96T
U0636r CLIA Fgf7,FGF-7,Fgf-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Kgf,Rat,Rattus norvegicus 96T
E0636m ELISA kit Fgf7,FGF-7,Fgf-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Mouse,Mus musculus 96T
E0636m ELISA Fgf7,FGF-7,Fgf-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Mouse,Mus musculus 96T
U0636m CLIA Fgf7,FGF-7,Fgf-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Mouse,Mus musculus 96T
E0636r ELISA Fgf7,FGF-7,Fgf-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Kgf,Rat,Rattus norvegicus 96T
U0636p CLIA FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Pig,Sus scrofa 96T
E0636p ELISA kit FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Pig,Sus scrofa 96T
E0636p ELISA FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF,Pig,Sus scrofa 96T
E0636c ELISA Canis familiaris,Canis lupus familiaris,Dog,FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF 96T
U0636c CLIA Canis familiaris,Canis lupus familiaris,Dog,FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF 96T
E0636c ELISA kit Canis familiaris,Canis lupus familiaris,Dog,FGF7,FGF-7,Fibroblast growth factor 7,HBGF-7,Heparin-binding growth factor 7,Keratinocyte growth factor,KGF 96T
CSB-EL008634DO Dog fibroblast growth factor 7 (keratinocyte growth factor) (FGF7) ELISA kit, Species Dog, Sample Type serum, plasma 96T
E1882h ELISA kit FGF10,FGF-10,Fibroblast growth factor 10,Homo sapiens,Human,Keratinocyte growth factor 2 96T
E1882h ELISA FGF10,FGF-10,Fibroblast growth factor 10,Homo sapiens,Human,Keratinocyte growth factor 2 96T
U1882h CLIA FGF10,FGF-10,Fibroblast growth factor 10,Homo sapiens,Human,Keratinocyte growth factor 2 96T
U1882h CLIA kit FGF10,FGF-10,Fibroblast growth factor 10,Homo sapiens,Human,Keratinocyte growth factor 2 96T
E1882m ELISA Fgf10,FGF-10,Fibroblast growth factor 10,Keratinocyte growth factor 2,Mouse,Mus musculus 96T
GS-0765a fibroblast growth factor 7 (keratinocyte growth factor) primary antibody, Host: Rabbit 200ul
U1882m CLIA kit Fgf10,FGF-10,Fibroblast growth factor 10,Keratinocyte growth factor 2,Mouse,Mus musculus 96T
U1882m CLIA Fgf10,FGF-10,Fibroblast growth factor 10,Keratinocyte growth factor 2,Mouse,Mus musculus 96T
E1882m ELISA kit Fgf10,FGF-10,Fibroblast growth factor 10,Keratinocyte growth factor 2,Mouse,Mus musculus 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur